台灣安美睿附屬於美國Amarex Clinical Research, LLC.,

其為全方位國際臨床試驗委托研究機構(CRO),在各臨床試驗階段之研究、探索、研發、驗證與許可上皆有豐富的成功經驗。

新型冠狀病毒

相關活動

IMAG1099.jpg
  • LinkedIn Social Icon
  • Facebook
  • Twitter
  • YouTube
22 October 2020

U.S. FDA Grants Fast Track Designation to Amarex Client PRG S&T Inc.

Amarex Taiwan, LLC, an NSF International company announced that the U.S. FDA granted Fast Track designation to Amarex’s client PRG S&T Inc. for PRG’s drug Progerinin, being tested as a treatment for Hutchinson-Gilford Progeria Syndrome (HGPS) and Werner Syndrome (WS). The Phase I study will be conducted in healthy subjects.

13 October 2020

Free webinar : Oncology Clinical Trials: An Emerging Paradigm Shift in Trial Design| October 27, 2020 11:00 AM EDT

Amarex Taiwan, LLC, an NSF International company’s Senior Vice President of Clinical Operations, Dr. Kush Dhody, will conduct a free webinar on Tuesday, October 27, 2020 at 11:00 a.m. EDT entitled Oncology Clinical Trials: An Emerging Paradigm Shift in Trial Design.

Register for this free webinar.

08 October 2020

Amytrx Enrolling Clinical Trial of AMTX-100 in Patients with Atopic Dermatitis

Amarex client, Amytrx Therapeutics (“Amytrx”), recently initiated clinical testing of their anti-inflammatory therapeutic product AMTX-100 for dermatological diseases and conditions with the enrollment of patients in a first-in-man Phase 1/2b study for treatment of mild to moderate atopic dermatitis.

22 September 2020

Amarex to Support AIM ImmunoTech in Regulatory Filings for Exciting Pancreatic Cancer Treatment under Development

Amarex Taiwan, LLC (Amarex) client AIM ImmunoTech Inc. (NYSE American: AIM) today announced receipt of statistically significant positive pancreatic cancer survival results from a multi-year Early Access Program (EAP) conducted at Erasmus Medical Center in the Netherlands.

來自最重要之人的推薦:我們的客戶。

醫療長

某家位於馬里蘭州的生技公司

我們與Amarex在眾多專案中展開了合作,他們通過廣泛的臨床與法規專業知識,始終如一提供我們高質量且可靠的服務。讓他們從其他CRO中脫穎而出的地方是藥物研發的創造性企業方法,他們不只專注於臨床試驗發展的技術方面,並積極與試驗委託者合作以提高價值並增加成功機會。

 5/5

★★★★★

技術長

某家加拿大傳染病研究組織

感謝Amarex團隊給予我們的試驗數據統計支持,其在FDA的最終審核中證明是非常寶貴且完全準確的,這一富含里程碑意義之成就的基石是來自於臨床研究的數據,並包括了檢測極限的研究,我們通過FDA所有的審查,並在整個過程中取得了扎實的結果。 在這裡,我們所有人都真誠地感謝Amarex團隊中所有參與這個專案的人,等到未來我們成功的將平台應用於其他醫療診斷器材的開發時,希望能與您再次合作。

 5/5

★★★★★

2F., No.19-10, Sanchong Rd., Nangang District, Taipei 115, TAIWAN |  +886-2-26553391

20.jpg